semaglutide intestinal blockage FDA updates Ozempic label to acknowledge some users' reports of blocked intestines Weighing the Risks: Small Bowel
Description
The glucagon receptor is not a red flag in this context
After 1 year without the medication, those in the obesity group regained an average of 0.5% of body weight, and those in the diabetes group lost an additional 1.3% of body weight on average
Both the vials and pens contain the same FDA-approved medication and are available in the same doses, with the same efficacy and potential side effects
doi: 10.1080/003655201750065906
